The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Size Growth Is Projected For The Therapeutic Drug Monitoring Market During The Forecast Period 2026–2030?
The therapeutic drug monitoring market has seen substantial expansion in recent years. This market is forecast to increase from $2.41 billion in 2025 to $2.67 billion in 2026, reflecting a compound annual growth rate (CAGR) of 10.9%. The market’s past growth can be attributed to several factors including the rising use of narrow therapeutic index drugs, the expansion of hospital laboratory testing, the adoption of immunoassay technologies, the growing prevalence of chronic diseases, and enhancements in analytical instrumentation.
The therapeutic drug monitoring market is projected to experience swift expansion over the coming years. Its valuation is set to reach $4.09 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.2%. This forecasted growth is primarily driven by an increasing need for precision medicine, the proliferation of automated diagnostic labs, a heightened emphasis on patient-tailored dosing, innovations in mass spectrometry technologies, and the rising uptake of real-time therapeutic monitoring. Significant trends anticipated during this period encompass the growing acceptance of LC-MS based monitoring methods, increased utilization of personalized medicine strategies, wider integration of automated laboratory systems, the broadening of real-time drug level analysis, and a stronger emphasis on precise dosing.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10069&type=smp
Which Major Factors Are Driving The Expansion Of The Therapeutic Drug Monitoring Market?
The escalating use of pharmaceutical substances is projected to stimulate the expansion of the therapeutic drug monitoring market in the future. These substances are applied medically to identify, manage, or avert illnesses in both humans and animals. Therapeutic drug monitoring serves to fine-tune drug dosage protocols by assessing and modifying drug levels within the bloodstream, thereby guaranteeing effectiveness while mitigating adverse effects. For example, in January 2024, data from the Office for Health Improvement & Disparities, a UK government department, indicated that between April 2022 and March 2023, a total of 12,418 young people under 18 sought assistance from alcohol and drug services. This figure represents a 10% rise from the 11,326 instances reported in the preceding year. Consequently, the growing consumption of drugs is propelling the therapeutic drug monitoring market.
What Market Segments Are Evaluated Within The Therapeutic Drug Monitoring Market?
The therapeutic drug monitoring market covered in this report is segmented –
1) By Product: Consumables, Equipment, Immunoassay Analyzers, Chromatography And Detectors
2) By Class Of Drug: Antiepileptic Drugs, Antibiotic Drugs, Immunosuppressant Drugs, Antiarrhythmic Drugs, Psychoactive Drugs, Other Drugs
3) By End-user: Hospital Laboratories, Commercial and Private Laboratories, Other End Users
Subsegments:
1) By Consumables: Reagents, Test Kits, Sample Collection Containers, Calibration Standards
2) By Equipment: Analyzers, Incubators, Centrifuges
3) By Immunoassay Analyzers: ELISA Analyzers, Chemiluminescent Immunoassay Analyzers, Radioimmunoassay Analyzers
4) By Chromatography And Detectors: High-Performance Liquid Chromatography (HPLC), Gas Chromatography (GC), Mass Spectrometry (MS)
What Industry Trends Are Redefining The Therapeutic Drug Monitoring Market?
Companies operating within the therapeutic drug monitoring market are prioritizing the advancement of anti-idiotypic antibody technology to elevate the sensitivity and specificity of assays, allowing for precise measurement of biologic drug levels and the assessment of patient immune responses. This anti-idiotypic antibody technology proves instrumental in therapeutic drug monitoring by enabling the accurate detection and quantification of biologic drug levels, thereby ensuring correct dosing and monitoring of patient immune responses. For example, in June 2024, Bio-Rad Laboratories, a US-based biotechnology company, introduced new anti-idiotypic and anti-monomethyl auristatin E (MMAE) antibodies for use in bioanalytical assays, which improve pharmacokinetic (PK) and antidrug-antibody (ADA) monitoring. These cutting-edge antibodies enhance the dependability of assays for antibody-drug conjugates (ADCs) and are vital for the therapeutic drug monitoring market, facilitating accurate evaluations of drug levels and immune responses to ensure optimal patient dosing.
Who Are The Top Market Participants Influencing The Therapeutic Drug Monitoring Market?
Major companies operating in the therapeutic drug monitoring market are Abbott Laboratories Inc., F. Hoffmann-La Roche AG, Siemens Healthineers AG, Thermo Fisher Scientific Inc., Sekisui Medical Co., Buehlmann Laboratories AG, Danaher Corporation, Bio-Rad Laboratories Inc., bioMérieux SA, Randox Laboratories Limited, Chromsystems Instruments & Chemicals GmbH, Grifols SA, Merck KGaA, BioChem Pharmaceuticals, Beckman Coulter Inc., DiaSorin S.p.A., Hologic Inc., Immunodiagnostic Systems Holdings plc, Kronus Inc., QuidelOrtho Corporation, Sysmex Corporation, TDM Solutions Inc., Theradiag, Tosoh Bioscience LLC, Trinity Biotech plc, Associated Regional and University Pathologists Inc., Mayo Clinic Laboratories, Quest Diagnostics
Read the full therapeutic drug monitoring market report here:
https://www.thebusinessresearchcompany.com/report/therapeutic-drug-monitoring-global-market-report
Which Region Currently Holds The Largest Share Of The Therapeutic Drug Monitoring Market?
North America was the largest region in the therapeutic drug monitoring market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global therapeutic drug monitoring market report during the forecast period. The regions covered in the therapeutic drug monitoring market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Therapeutic Drug Monitoring Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=10069&type=smp
Browse Through More Reports Similar to the Global Therapeutic Drug Monitoring Market 2026, By The Business Research Company
Pharmaceuticals Market 2026
https://www.thebusinessresearchcompany.com/report/pharmaceuticals-market
Pharmaceutical Label Market Report 2026
https://www.thebusinessresearchcompany.com/report/pharmaceutical-label-global-market-report
Pharmaceuticals Market 2026
https://www.thebusinessresearchcompany.com/report/pharmaceuticals-market
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model